Put the CAR-T before the HRS: Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma. This evidence concerns the gene TNFRSF8 and classic Hodgkin lymphoma.